3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Conditions
Whooping Cough
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pneumococcal Infections
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Measles
1
Lymphoma, Non-Hodgkin
1
Leukemia, Myeloid, Acute
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Hodgkin Disease
1
Hepatitis B
1
HIV Infections
1
Interventions
fludarabine phosphate
10
Cyclophosphamide
10
Peripheral Blood Stem Cell Transplantation
9
Cyclosporine
7
Mycophenolic Acid
6
Filgrastim
6
Antilymphocyte Serum
6
Whole-Body Irradiation
5
Busulfan
5
Radiotherapy
4
Psychiatric Rehabilitation
4
Cytarabine
4
Methylprednisolone
3
Methotrexate
3
Melphalan
3
Cord Blood Stem Cell Transplantation
3
Aprepitant
3
thymoglobulin
2
Therapeutics
2
Tacrolimus
2
Polymerase Chain Reaction
2
Ondansetron
2
Mesna
2
Flow Cytometry
2
Dexamethasone
2
Calcium Dobesilate
2
Analgesia
2
sargramostim
1
plerixafor
1
fludarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Myeloproliferative Disorders
×
Tetanus Toxoid
×
Clear all
NCT01611298
2020-04-21
TAR
Baylor College of Medicine
Phase NA
Completed
7 enrolled
8 charts